Protara Therapeutics TARA
NASDAQ TARA
$2.33 -0.11 (-4.51%)
At close: Oct 23, 2026 · 4:00 PM EDT

Protara Therapeutics (TARA) Price to Sales (2020 - 2026)

Updated

Protara Therapeutics' Price to Sales was 432.44 in FY2014.

Analysis

Protara Therapeutics (TARA) Price to Sales (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Protara Therapeutics 142.76 Mn -423.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 81.60
Jun 30, 2025 83.44
Sep 30, 2020 593.81
Jun 30, 2020 103.64
API Access

Protara Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=TARA&period=max&api_key=YOUR_API_KEY